Fast path: latest quarter results by ticker or company name

Home / LIMN / Company Profile

Liminatus Pharma Inc Class A Common Stock

LIMN | Healthcare | NASDAQ
Website Reports Financials
$0.11
+0.01 (+6.77%)

Key Metrics

Market Cap
$2.84M
P/E Ratio
-0.59
EPS
$-0.18
Beta
N/A
Dividend Yield
N/A
ROE
215.73%
Current Ratio
0.96

Company Information

Industry
Biotechnology

About Liminatus Pharma Inc Class A Common Stock

Liminatus Pharma Inc is an immunooncology firm currently in its clinical development phase dedicated to pioneering new treatments for cancer The companys headquarters are located in La Palma California

Financial Ratios (TTM)

Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
0.00%
ROA
-394.33%
Price to Book
-18.94
Price to Sales
0.00